A Systematic Switch From Originator Infliximab to Biosimilar Infliximab in Patients With Non-

Kumar, N; Follestad, T; Sen, HN; Austeng, D

Kumar, N (corresponding author), Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Ophthalmol, N-7006 Trondheim, Norway.

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021; 225 (): 178

Abstract

center dot PURPOSE: To investigate the efficacy of biosimilar infliximab compared to that of the originator infliximab for the treatment of chronic no......

Full Text Link